Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for acne and post-inflammatory erythema/hyperpigmentation
ChiCTR2400085761Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in acne vulgaris, Postinflammatory erythema (PIE) and Post-inflammatory hyperpigmentation (PIH) comparing Research group (tranexamic acid) with Control group (placebo) (2 arms). Primary endpoints: Acne vulgaris severity scale (GAGS score), Investigator Global Assessment (IGA) and 5 more. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
acne vulgarisPostinflammatory erythema (PIE)Post-inflammatory hyperpigmentation (PIH)
Beyond the preview
Go deeper on ChiCTR2400085761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085761.